MedTrace Logo

Corticosteroid Reduction in COPD

NCT02857842 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2019-02-08

No results posted yet for this study

Summary

This study explores whether patients hospitalized with chronic obstructive pulmonary disease (COPD) exacerbation may have fewer days with prednisolone and with the same treatment effect by controlling the treatment by daily measurements of eosinophils.

Conditions

  • Lung Diseases, Obstructive
  • Blood Eosinophil Count
  • Glucocorticoids
  • COPD
  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Prednisolone

Sponsors & Collaborators

  • Chronic Obstructive Pulmonary Disease Trial Network, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-09-30
Completion
2019-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02857842 on ClinicalTrials.gov